SCHEMBL5843067

SCHEMBL5843067

O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C\c1c[nH]c2ccccc12

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NTRK1 P04629 8/20 0.80
▸ SYK P43405 4/20 0.80
▸ NTRK3 Q16288 4/20 0.67
▸ NTRK2 Q16620 4/20 0.67
▸ RET P07949 3/20 0.67
▸ KDR P35968 3/20 0.67
▸ PRKD3 O94806 2/20 0.67
▸ ABL1 P00519 2/20 0.67
▸ PDGFRB P09619 2/20 0.67
▸ LTK P29376 2/20 0.67
▸ FLT3 P36888 2/20 0.67
▸ CSNK1A1 P48729 2/20 0.67
▸ CDK7 P50613 2/20 0.67
▸ MAP2K1 Q02750 2/20 0.67
▸ MST1R Q04912 2/20 0.67
▸ AURKB Q96GD4 2/20 0.67
▸ CLK4 Q9HAZ1 2/20 0.67
▸ ALK Q9UM73 2/20 0.67
▸ DAPK3 O43293 1/20 0.67
▸ MAP4K4 O95819 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5181885 1.00 NTRK1 (0.80) NTRK1SYKNTRK3NTRK2RET
SCHEMBL5182671 0.89 NTRK1 (1.00) NTRK1SYKNTRK3NTRK2RET
SCHEMBL5182676 0.89 NTRK1 (1.00) NTRK1SYKNTRK3NTRK2RET
SCHEMBL8585618 0.87 NTRK1 (0.67) NTRK1SYKNTRK3NTRK2RET
SCHEMBL8585615 0.87 NTRK1 (0.67) NTRK1SYKNTRK3NTRK2RET
SCHEMBL5181559 0.86 NTRK1 (0.76) NTRK1SYKNTRK3NTRK2RET
SCHEMBL5181556 0.86 NTRK1 (0.76) NTRK1SYKNTRK3NTRK2RET
SCHEMBL5420371 0.86 NTRK1 (0.76) NTRK1SYKNTRK3NTRK2RET
SCHEMBL5420368 0.86 NTRK1 (0.76) NTRK1SYKNTRK3NTRK2RET
SCHEMBL14448928 0.84 NTRK1 (0.73) NTRK1SYKNTRK3NTRK2RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 — — US claimed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 — — WO claimed
US-7071332-B2 Indolinone derivatives as protein kinase/phosphatase inhibitors SUGEN, INC. (US) 2006-07-04 — — US disclosed
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 — — US disclosed
EP-0752985-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1997-01-15 — — EP disclosed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 — — WO disclosed
Send feedback